GANSID Congress calls for better care for inherited blood disorders

The 4th GANSID Congress 2026 concluded after three days of discussions on inherited blood disorders. Delegates from 23 countries examined prevention, early diagnosis, equitable healthcare access, bone marrow transplant assistance and collaborative approaches to improving patient care and long-term outcomes.

Hyderabad: The 4th GANSID Congress 2026 concluded its three-day international conference, uniting global experts to tackle inherited blood disorders like sickle cell disease and thalassemia.

Organised in collaboration with the Thalassemia and Sickle Cell Society (TSCS), Hyderabad, the event drew delegates from 23 countries alongside nationwide participants.

---

The inaugural ceremony featured retired IAS officer Vinod K Agrawal as Chief Guest, alongside dignitaries from the National Health Authority, Pfizer India, and GANSID.

Discussions centered on advancing prevention, early diagnosis, and equitable healthcare access. TSCS, supporting over 4,800 patients locally, highlighted the critical need for collaborative patient care initiatives, including bone marrow transplant assistance and antenatal screening.

The congress successfully fostered international partnerships, scientific knowledge exchange, and a collective commitment to enhancing the long-term quality of life for affected individuals and their families worldwide.

Stakeholders emphasised that coordinated action among medical professionals, researchers, policymakers, and patient organisations is vital for building sustainable support systems. The congress reaffirmed a shared global commitment to expanding access to advanced treatments and improving the overall quality of life for patients and their families worldwide.